Nycomed to co-market Orion's Easyhaler products in Europe and MENA region
This article was originally published in Clinica
Executive Summary
Nycomed has entered into a collaboration agreement with Orion to co-market two Easyhaler combination products for the treatment of asthma and chronic obstructive pulmonary disease (COPD) in the major European countries. It has also obtained an additional exclusive licence and distribution arrangement for the Middle East and North Africa region (MENA).